Search Results - "URWIN, G. H"

The role of percutaneous nephrostomy in malignant ureteric obstruction by Wilson, J R, Urwin, G H, Stower, M J

“…Uraemia as a result of malignant ureteric obstruction is a recognised event in those with advanced malignancy, usually of pelvic origin, which, if left…”
Get full text

The changing practice of transurethral prostatectomy: a comparison of cases performed in 1990 and 2000 by Wilson, J R, Urwin, G H, Stower, M J

“…Transurethral resection of the prostate (TURP) is considered by many to be the 'gold standard' treatment for benign prostatic enlargement. However, with the…”
Get full text

The catheterized patient undergoing transurethral resection of the prostate: a survey of the current practice of British urologists by Wilson, J.R., Puri, R., Prescott, S., Urwin, G.H.

“…OBJECTIVE To determine, using a postal questionnaire survey of practising British consultant urologists, the duration and type of antibiotic deemed most…”
Get full text

Biochemical and histological evidence that carcinoma of the prostate is associated with increased bone resorption by Percival, R C, Urwin, G H, Harris, S, Yates, A J, Williams, J L, Beneton, M, Kanis, J A

“…We have investigated the hypothesis that carcinoma of the prostate with skeletal metastases is associated with increased bone resorption. In 54 affected…”
Get more information

Limitations of ultrasound evaluation in acute closed renal trauma by Perry, M J, Porte, M E, Urwin, G H

“…Imaging of the kidneys following acute closed renal trauma may be undertaken using one of several available modalities. Ultrasound evaluation is often the…”
Get more information

Pancreatic pseudocyst: a urological emergency? by CONDON, L. T, URWIN, G. H, ALEXANDER, D. J

Get full text

Generalised increase in bone resorption in carcinoma of the prostate by Urwin, G H, Percival, R C, Harris, S, Beneton, M N, Williams, J L, Kanis, J A

“…Several indirect biochemical indices of bone resorption are increased in patients with carcinoma of the prostate and skeletal metastases. We have examined…”
Get more information

Bilateral ureteric strictures after intravesical mitomycin C by Wass, A R, Lawson, T R, Urwin, G H

Get more information

Aminohexane diphosphonate in the treatment of Paget's disease of bone by ATKINS, R. M, YATES, A. J. P, GRAY, R. E. S, URWIN, G. H, HAMDY, N. A. T, BENETON, M. N. C, ROSINI, S, KANIS, J. A

“…We studied the effects of the intravenous or oral administration of aminohexane diphosphonate (AHDP) in 42 patients with active Paget's disease of bone…”
Get full text

Assessment of thallium-pertechnetate subtraction scintigraphy in hyperparathyroidism by Percival, R C, Blake, G M, Urwin, G H, Talbot, C H, Williams, J L, Kanis, J A

“…Reliable techniques for detecting and localising abnormal parathyroid tissue have been a persistent problem. We have evaluated thallium-pertechnetate…”
Get more information

Testicular infarction in a patient with sickle cell trait by Urwin, G H, Kehoe, N, Dundas, S, Fox, M

Get more information

Carcinoma of the colon as a late complication of ureterosigmoidostomy by Urwin, G H, Williams, J L

Get more information

Biochemical markers and skeletal metabolism in carcinoma of the prostate. Use of decision matrix theory and ROC analysis by Urwin, G H, Percival, R C, Yates, A J, Watson, M E, Couch, M, McDonald, B, Forrest, A R, Williams, J L, Kanis, J A

“…The discriminative ability of several skeletal and tumour markers was assessed in 102 patients with prostatic disease. These comprised serum acid and alkaline…”
Get more information

Thallium-technetium subtraction scintigraphy as an aid to parathyroid surgery by Percival, R C, Blake, G M, Urwin, G H, Williams, J L, Kanis, J A

“…We describe the application of thallium-technetium subtraction scintigraphy in nine patients with failed previous parathyroid surgery or with tertiary…”
Get more information

Treatment of the hypercalcaemia of malignancy with intravenous clodronate by Urwin, G H, Yates, A J, Gray, R E, Hamdy, N A, McCloskey, E V, Preston, F E, Greaves, M, Neil, F E, Kanis, J A

“…We studied the effects of intravenous clodronate (100-300 mg daily for 3-10 days) in 27 episodes of hypercalcaemia due to malignancy. Comparisons were also…”
Get more information

Intravenous clodronate in the treatment and retreatment of Paget's disease of bone by Yates, A J, Percival, R C, Gray, R E, Atkins, R M, Urwin, G H, Hamdy, N A, Preston, C J, Beneton, M N, Russell, R G, Kanis, J A

“…The effects of short courses (5 days) of intravenous clodronate 300 mg daily were studied in 31 patients with active Paget's disease of bone. The diphosphonate…”
Get more information

Effects of intravenous etidronate disodium on skeletal and calcium metabolism by Kanis, J A, Urwin, G H, Gray, R E, Beneton, M N, McCloskey, E V, Hamdy, N A, Murray, S A

“…The induction of hypercalcemia in malignant disease is almost invariably associated with increased bone resorption. However, tumor-induced changes in bone…”
Get more information

Prostatic carcinoma by Urwin, G H

Get full text

Effects of diphosphonates in hypercalcaemia due to neoplasia by Kanis, J A, Percival, R C, Yates, A J, Urwin, G H, Hamdy, N A

Get more information

Short term high doses of etidronate in Paget's disease of bone by Kanis, J A, Gray, R E, Murray, S A, Hamdy, N A, Urwin, G H

Get full text